Kessler documents his experience in the new book Diet, Drugs, and Dopamine: The New Science of Achieving a Healthy Weight
The goal is for the "quadruple-action" medication to achieve long-lasting weight loss of up to 30% matching the effectiveness of bariatric surgery, which reduces the size of the stomach, according to a study press release
Some patients may also experience abdominal pain or discomfort
This way, there can be better representation in medical research, and greater access to medications, treatments, and support for conditions like type 2 diabetes and obesity
Most GLP-1 prescriptions are written by primary care physicians, endocrinologists, and telehealth providers who may have limited training in eating disorder identification
But if someone has tried more established interventions without success, she says, it might be worth trying a GLP-1 agonist to address addiction